J. Pharm. Pharmacogn. Res., vol. 14, no. 1, Article ID 2475, Jan-Feb 2026.
DOI: https://doi.org/10.56499/jppres_14.1.2475
Original Article
Effectiveness as tyrosinase inhibitor from active compounds of Centella asiatica (L.) Urb., ethyl ascorbic acid, and coenzyme Q10 as skin whitening by in silico evaluation
[Eficacia como inhibidor de la tirosinasa de compuestos activos de Centella asiatica (L.) Urb., ácido etilascórbico y coenzima Q10 para el blanqueamiento de la piel mediante la evaluación in silico]
Ni L. D. Aryani1, Dini Kesuma2*, Armiza D. Yasinta1, Elya Andreyana2
1Department of Pharmaceutics, Faculty of Pharmacy, University of Surabaya, Surabaya, Indonesia.
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Surabaya, Surabaya, Indonesia.
*E-mail: dinikesuma@gmail.com, dini_kesuma@staff.ubaya.ac.id
Abstract
Context: Hyperpigmentation and melasma are often treated with hydroquinone-based topical creams. Despite its effectiveness, hydroquinone use is limited by irritation, photosensitivity, and oxidation sensitivity, making long-term application unfavorable.
Aims: To explore Centella asiatica phytochemicals as natural alternatives in topical formulations, in combination with oxidative chemical agents such as ethyl ascorbic acid and coenzyme Q10, through preliminary in silico evaluation.
Methods: Molecular docking and molecular dynamics simulations were conducted on asiatic acid, madecassic acid, asiaticoside, and madecassoside from C. asiatica, along with ethyl ascorbic acid and coenzyme Q10, against the tyrosinase enzyme (PDB: 5I3A). Docking was performed using Molegro Virtual Docker (Molexus v7), and molecular dynamics simulations were carried out in Maestro (Schrödinger) for 100 ns.
Results: Asiatic acid exhibited the most promising activity, with binding affinity comparable to hydroquinone and stable interactions during 100 ns simulations (average RMSD ~3 Å). Glycoside derivatives (asiaticoside and madecassoside) showed weak and unstable binding. Notably, 3-o-ethyl ascorbic acid demonstrated stronger binding energy and superior stability (average RMSD 2.971 Å) than hydroquinone, whereas coenzyme Q10 displayed positive binding free energy and poor stability.
Conclusions: The findings suggest that asiatic acid is the most active anti-hyperpigmentation compound in C. asiatica, while glycosides lack tyrosinase inhibitory activity. Incorporation of 3-o-ethyl ascorbic acid, rather than coenzyme Q10, could enhance the efficacy of C. asiatica–based topical formulations for hyperpigmentation management.
Keywords: Centella asitica; molecular docking; molecular dynamics; hyperpigmentation; tyrosinase.

Resumen
Contexto: La hiperpigmentación y el melasma a menudo se tratan con cremas tópicas a base de hidroquinona. A pesar de su eficacia, el uso de hidroquinona está limitado por la irritación, la fotosensibilidad y la sensibilidad a la oxidación, lo que hace que la aplicación a largo plazo resulte desfavorable.
Objetivos: Explorar los fitoquímicos de Centella asiática como alternativas naturales en formulaciones tópicas, en combinación con agentes químicos oxidativos como el ácido etil ascórbico y la coenzima Q10, mediante evaluación preliminar in silico.
Métodos: Se realizaron simulaciones de acoplamiento molecular y dinámica molecular de ácido asiático, ácido madecásico, asiaticósido y madecasósido de C. asiatica, junto con ácido etilascórbico y coenzima Q10, contra la enzima tirosinasa (PDB: 5I3A). El acoplamiento se realizó con Molegro Virtual Docker (Molexus v7) y las simulaciones de dinámica molecular se realizaron en Maestro (Schrödinger) durante 100 ns.
Resultados: El ácido asiático exhibió la actividad más prometedora, con una afinidad de unión comparable a la de la hidroquinona y interacciones estables durante simulaciones de 100 ns (RMSD promedio de ~3 Å). Los derivados de glucósidos (asiaticósido y madecasósido) mostraron una unión débil e inestable. En particular, el ácido 3-o-etilascórbico demostró una energía de unión más alta y una estabilidad superior (RMSD promedio de 2,971 Å) que la hidroquinona, mientras que la coenzima Q10 mostró una energía libre de unión positiva y una estabilidad deficiente.
Conclusiones: Los hallazgos sugieren que el ácido asiático es el compuesto antihiperpigmentación más activo en C. asiatica, mientras que los glucósidos carecen de actividad inhibidora de la tirosinasa. La incorporación de ácido 3-o-etilascórbico, en lugar de la coenzima Q10, podría mejorar la eficacia de las formulaciones tópicas basadas en C. asiatica para el tratamiento de la hiperpigmentación.
Palabras Clave: acoplamiento molecular; Centella asiática; dinámica molecular; hiperpigmentación; tirosinasa.

Citation Format: Aryani NLD, Kesuma D, Yasinta AD, Andreyana E (2026) Effectiveness as tyrosinase inhibitor from active compounds of Centella asiatica (L.) Urb., ethyl ascorbic acid, and coenzyme Q10 as skin whitening by in silico evaluation. J Pharm Pharmacogn Res 14(1): 2475. https://doi.org/10.56499/jppres_14.1.2475
References
Arunan E, Desiraju G, Klein R, Sadlej J, Scheiner S, Alkorta I, Clary D, Crabtree R, Dannenberg J, Hobza P, Kjaergaard H, Legon A, Mennucci B, Nesbitt D (2011) Definition of the hydrogen bond (IUPAC Recommendations 2011). Pure Appl Chem 83(8): 1637–1641. https://doi.org/10.1351/PAC-REC-10-01-02
Atapour-Mashhad H, Tayarani-Najaran Z, Golmohammadzadeh S (2024) Preparation and characterization of novel nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN) containing coenzyme Q10 as potent antioxidants and antityrosinase agents. Heliyon 10(11): e31429. https://doi.org/10.1016/j.heliyon.2024.e31429
Badal MS, Delgoda R (2016) Pharmacognosy: Fundamentals, Applications and Strategies. London: Academic Press.
Boateng ST, Roy T, TorreyK, Owunna U, Banang-Mbeumi S, Basnet D, Niedda E, Alexander ED, El Hage D, Atchimnaidu S, Nagalo BM, Aryal D,Findleyc A, Seeram NP, Efimova T, Sechi M, Hill RA, Ma H, Christopher J, Murru S (2023) Synthesis, in-silico modelling, and in-vitro biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents. J Enzyme Inhib Med Chem 38(1): 2205042. https://doi.org/10.1080/14756366.2023.2205042
Chang TS (2009) An updated review of tyrosinase inhibitors. Int J Mol Sci 10(6): 2440–2475. https://doi.org/10.3390/ijms10062440
Chen SJ, Hseu YC, Vudhya Gowrisankar Y, Chung YT, Zhang YZ, Way TD, Yang HL (2021) The anti-melanogenic effects of 3-o-ethyl ascorbic acid via NRF2-mediated α-MSH inhibition in UVA-irradiated keratinocytes and autophagy induction in melanocytes. Free Radic Biol Med 173: 151–169. https://doi.org/10.1016/j.freeradbiomed.2021.07.030
Deri B, Kanteev M, Goldfeder M, Lecina D, Guallar V, Adir N, Fishman A (2016) The unravelling of the complex pattern of tyrosinase inhibition. Sci Rep 6: 34993. https://doi.org/10.1038/srep34993
Dipiro JT, Yee GC, Posey M, Haines ST, Nolin TD, Ellingrod V (2020) Pharmacotherapy: A pathophysiologic approach. 11th ed. New York: McGraw-Hill.
Ekowati J, Tejo BA, Maulana S, Kusuma WA, Fatriani R, Ramadhanti NS, Nofianti KA, Sulistyowaty MI, Zubair MS, Yamauchi T, Hamid IS (2023) Potential utilization of phenolic acid compounds as anti-inflammatory agents through TNF-α convertase inhibition mechanisms: A network pharmacology, docking, and molecular dynamics study. ACS Omega 8(49): 46851–46868. https://doi.org/10.1021/acsomega.3c06450
Fernenda L, Ramadhani AP, Syukri Y (2023) Review: Centella asiatica (L.) Urban activity in dermatology. J Sains Farm Klin 9(3): 237–244. https://doi.org/10.25077/jsfk.9.3.237-244.2022
Ghahremanian S, Rashidi MM, Raeisi K, Toghraie D (2022) Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: A structural review. J Mol Liq 354: 118901. https://doi.org/10.1016/j.molliq.2022.118901
Greenidge PA, Kramer C, Mozziconacci JC, Wolf RM (2012) MM/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement. J Chem Inf Model 53(1): 201–209. https://doi.org/10.1021/ci300425v
Halgren TA (1996) Merck Molecular Force Field. I Basis, form, scope, parametrization, and performance of MMFF94. J Com Chem 17(5-6): 490–519. https://doi.org/10.1002/(SICI)1096-987X(199604)17:5/6%3C490::AID-JCC1%3E3.0.CO;2-P
Harahap A, Triamarta S, Kharisma D, Hanifah W, Iqbal M, Arifa N, Ismed F (2024) Evaluation of the anti-tyrosinase-anti-aging potential and metabolite profiling from the bioactive fraction of corn cob (Zea mays L.). Int J App Pharm 16(Special Issue 1): 71–76. https://doi.org/10.22159/ijap.2024.v16s1.18
Henzler-Wildman K, Kern D (2007) Dynamic personalities of proteins. Nature 450(7172): 964–972. https://doi.org/10.1038/nature06522
Hou T, Wang J, Li Y, Wang W (2011) Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J Chem Inf Model 51(1): 69–82. https://doi.org/10.1021/ci100275a
Iliopoulos F, Sil BC, Moore DJ, Lucas RA, Lane ME (2019) 3-O-ethyl-l-ascorbic acid: Characterisation and investigation of single solvent systems for delivery to the skin. Int J Pharm X 1: 100025. https://doi.org/10.1016/j.ijpx.2019.100025
Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JAG (2023) Coenzyme Q10 and dementia: A systematic review. Antioxidants 12(2): 533. https://doi.org/10.3390/antiox12020533
Kesuma D, Yuniarta TA, Suherto AD, Putra GS, Sutrisno S, Anwari F (2025) Synthesis, molecular docking, molecular dynamics, pharmacokinetics prediction and bioassay of N(phenylcarbamothioyl)-4-chlorobenzamide as anti-breast cancer candidate. J Pharm Pharmacogn Res 13(2): 551–564. https://doi.org/10.56499/jppres24.2092_13.2.551
Liu L, Wang H, Chai X, Meng Q, Jiang S, Zhao F (2022) Advances in biocatalytic synthesis, pharmacological activities, pharmaceutical preparation and metabolism of ginsenoside Rh2. Mini Rev Med Chem 22(3): 437–448. https://doi.org/10.2174/1389557521666210913114631
Lobanov MY, Bogatyreva NS, Galzitskaya OV (2008) Radius of gyration as indicator of protein structure compactness. Mol Biol (Moscow) 42(4): 623–628. https://doi.org/10.1134/S0026893308040195
Noh H, Lee SJ, Jo HJ, Choi HW, Hong S, Kong KH (2020) Histidine residues at the copper-binding site in human tyrosinase are essential for its catalytic activities. J Enzyme Inhib Med Chem 35(1): 726–732. https://doi.org/10.1080/14756366.2020.1740691
Prasetyo A, Mumpuni E, Luthfiana D, Herowati R, Putra GS (2025) In silico discovery of potential sodium-glucose cotransporter-2 (SGLT-2) inhibitors from Smallanthus sonchifolius (Poepp.) H.Rob. via molecular docking and molecular dynamics simulation approach. J Pharm Pharmacogn Res 13(3): 716–728. https://doi.org/10.56499/jppres24.2104_13.3.716
Putra GS, Sulistyowaty MI, Yahmin Y, Sumari S, Retnosari R, Marfu’ah S, Anwari F, Suhud F, Kesuma D, Ma’arif B, Mardianto R, Sukkaew A, Yamauchi T (2025) In silico and in vitro antimalarial activity evaluation of eugenol’s transformation products against Plasmodium falciparum strain 3D7 using the Trager and Jensen method. J Pharm Pharmacogn Res 13(s1): S347–S370. https://doi.org/10.56499/jppres24.2286_13.s1.347
Putra GS, Sulistyowaty MI, Yuniarta TA, Yahmin Y, Sumari S, Saechan C, Yamauchi T (2023) QSAR study of benzylidene hydrazine benzamides derivatives with in vitro anticancer activity against human lung cancer cell line A459. J Pharm Pharmacogn Res 11(6): 1123–1136. https://doi.org/10.56499/jppres23.1718_11.6.1123
Ruswanto R, Nofianti T, Mardianingrum R, Kesuma D, Siswandono (2022) Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment. Heliyon 8(9): e10694. https://doi.org/10.1016/j.heliyon.2022.e10694
Slominski RM, Sarna T, Płonka PM, Raman C, Brożyna AA, Slominski AT (2022) Melanoma, melanin, and melanogenesis: The Yin and Yang relationship. Front Oncol 12: 842496. https://doi.org/10.3389/fonc.2022.842496
Solano F (2020) Photoprotection and skin pigmentation: Melanin-related molecules and some other new agents obtained from natural sources. Molecules 25(7): 1537. https://doi.org/10.3390/molecules25071537
Steiner T (2002) The hydrogen bond in the solid state. Angew Chem Int Ed Engl 41(1): 49–76. https://doi.org/10.1002/1521-3773(20020104)41:1%3C48::AID-ANIE48%3E3.0.CO;2-U
Sulistyowaty MI, Nugroho AE, Putra GS, Ekowati J, Budiati T (2016) Syntheses, molecular docking study and anticancer activity examination of p-methoxycinnamoyl hydrazides. Int J Pharm Clin Res 8(6): 623–627.
Sulistyowaty MI, Putra GS, Budiati T, Indrianingsih AW, Anwari F, Kesuma D, Matsunami K, Yamauchi T (2023) Synthesis, in silico study, antibacterial and antifungal activities of N-phenylbenzamides. Int J Mol Sci 24(3): 2745. https://doi.org/10.3390/ijms24032745
Suyanto FC, Saraswati PDA (2023) Terapi laser untuk lesi hiperpigmentasi. Cermin Dunia Kedokt 50(8): 419-425. https://doi.org/10.55175/cdk.v50i8.757
Sweetman SC (2009) Martindale: The Complete Drug Reference 36th ed. London: Pharmaceutical Press.
Walle T, Browning AM, Steed LL, Reed SG, Walle UK (2005) Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J Nutr 135(1): 48–52. https://doi.org/10.1093/jn/135.1.48
Widiyana AP, Putra GS, Muchlashi LA, Sulistyowaty MI, Budiati T (2016) Design and molecular docking studies of quinazoline derivatives as antiproliferation. J Farm Ilmu Kefarm Indones 3(2): 44–48. https://doi.org/10.20473/jfiki.v3i22016.44-48
Yousefi S, Bayat S, Abdul Rahman MB, Ismail IS, Saki E, Abdulmalek E (2015) Synthesis and in vitro bioactivity evaluation of new glucose and xylitol ester derivatives of 5-aminosalicylic acid. RSC Adv 5: 97295–97307. https://doi.org/10.1039/C5RA19623J
Zhang CP, Liu G, Hu FL (2012) Hydrolysis of flavonoid glycosides by propolis β-glycosidase. Nat Prod Res 26(3): 270–273. https://doi.org/10.1080/14786419.2010.541877
© 2026 Journal of Pharmacy & Pharmacognosy Research